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active treatment rather than a negative lack of treatment or,
as Professor Stjernsward puts it, 'a waste-paper basket alter-
native' runs throughout the text and unifies the whole. The
holistic and interdisciplinary nature of palliative care is
emphasised by comprehensive and well-written chapters on
ethical, cultural and spiritual issues and bereavement. The
section on rehabilitation is noteworthy in that it covers topics
as diverse as stoma management and music therapy as well
as incontrovertibly demonstrating that rehabilitation is an
intrinsic part of palliative medicine.
The importance of research in palliative care is a recurring
theme throughout the book, and a specific section is devoted
to this topic. Studies in this field are, however, relatively
sparse, and the reasons for this are acknowledged and duly
addressed. In particular, Calman and Hanks refer to the
widespread view that 'scientifically rigorous clinical research
is incompatible with the basic tenets of palliative care', and
they put forward cogent arguments to refute this. This sec-
tion of the book is extremely wide-ranging, and discussion is
not limited to research into pharmacological and non-
pharmacological symptom management as nursing, psycho-
logical and social issues are also well covered. The fact that
palliative care crosses the traditional barriers of discipline
and specialty is highlighted in the section on education and
training. The authors stress that all the members of any
hospital-based or domiciliary team caring for patients with
cancer, be they doctors, nurses, social workers, physio-
therapists or clergy, need at least a working knowledge of the
philosophy of palliative care and suggest that this subject
should become an integral part of the curriculum of all
student health care professionals.
Although multiauthorship can bring problems through
inevitable variability of both style and approach, these are
not very apparent and there is a uniformly high standard of
presentation throughout the book. Despite a degree of over-
lap between chapters there is surprisingly little repetition. The
textbook is well indexed and all of the chapters are more
than adequately referenced. In parts, the text is rather dry
and it is tempting to speculate that it could be lightened by
more case histories and illustrations.
The book concludes with a thought-provoking dissertation
on the global perpsective of palliative medicine. Each year
fifty million people die worldwide. At least 10% die of
malignant disease, and it is likely that this proportion, in
addition to the numbers dying from AIDS-related diseases,
will continue to increase. Given that even in resource-rich,
developed nations there is inadequate application of the
available knowledge on palliative care, it is perhaps not
surprising that globally this field of medicine is badly
neglected. To rectify this situation changes are necessary not
only in medical practice but also in political, socioeconomic,
social and ethical arenas. The World Health Organization
has designated palliative care a priority in its Global Cancer
Control Programme, and encouraging progress is already
being achieved.
The Oxford Textbook ofPalliative Medicine is a book both
to dip in to, at leisure and when faced with an urgent clinical
problem to solve, and to read systematically to gain a full
insight into this field. Whilst its publication undoubtedly
represents a coming of age of palliative medicine as a
specialty in its own right, it is equally obvious that this new
specialty must continue to evolve.
Carol L. Davis
Chemoradiation. An Integrated Approach to Cancer Treatment
Edited by M.J. John, M.S. Flam. S.S. Legha & T.L. Phillips,
Philadelphia: Lea & Febiger, 1993. 688 pp. £75.00.
This book sets out to put forward the rationale for and
history to date of integrating chemotherapy and radiation in
the management of cancer. The book is divided into five
sections, with a brief introduction, the biological principles
underlining combined modality therapy, a clinical section
covering 17 disease sites, a section on toxicity and an appen-
dix summarising current clinical trials addressing the issue.
The second section includes some basic information about
the mechanisms and action of both radiation and cytotoxic
drugs, but most attention is focused on their use as sole
modalities with little information about possible interactions.
The clinical chapters are comprehensive and give an excellent
overview of combined modality therapy in the individual
disease sites. The section on toxicity tends to reproduce some
of the information included in the clinical chapters. Overall,
this book may be useful as a reference source in a depart-
mental library but it is unlikely to be of everyday relevance
to the majority of oncology clinicians.
G.M. Duchesne
New Approaches in Cancer Pharmacology: Drug Design and
Development
Edited by P. Workman, Berlin: Springer-Verlag, 1992,
103 pp.
This European School of Oncology Monograph recounts the
deliberations of a Task Force set up to examine current
progress and to anticipate future trends in cancer drug dis-
covery and pharmacology. The underlying theme is the need
for more effective drugs and the exciting opportunities
offered by the present understanding of the discrete mole-
cular abberations ofmalignant cells which provide targets for
selective attack. The contributors are all acknowledged
experts in their fields and this short monograph is well
written, authoritative and readable.
The review on sequence- and gene-specific drugs by D'In-
calci, Broggini and Hartley concentrates on alkylating agents
and their reactions with DNA as the major biochemical
events underpinning their cytotoxicities. It has been known
for some time that DNA damage is attributable to single-
and double-strand breaks, inter- and intra-strand cross-links
and possibly to DNA-protein cross-links. The site most
frequently alkylated is guanine N7, with lesser reaction occur-
ring at guanine 06 and adenine N3. The authors review
methodology which now enables an understanding of how
DNA base sequences influence the sites of alkylation of
various clinically used alkylating agents. It is now clear that
many common bifunctional alkylating agents react preferen-
tially with guanine N7 in contiguous runs of guanines in the
major groove of DNA. The authors emphasise that these
studies are carried out with parent drug and purified DNA
and take no account of cellular metabolism. Minor groove
binders include mitomycin C and CC-1065.
Claude Helene discussed antisense and antigene oligo-
nucleotides and synthetic ribozymes. The major requirements
of antisense oligos are emphasised: nuclease stability; preser-
vation of RNAse H activity; good cell penetration. The
advantages and shortcomings of the various linker chemis-
tries and the properties of chimaeric molecules comprising
conventional phosphodiester linkers in association with
methyl phosphonate, phosphorothioate or phosphoramidate
units is reviewed. Other chemical manoeuvres, including
coupling of oligos to hydrophobic moieties to enhance trans-
port and attachment of alkylating residues, both to achieve
nuclease stability and to increase potency, are mentioned
also. A consistent theme is the high selectivity that can be
achieved with antisense oligonucleotides in their effects, for
example on parasitically or virally infected cells, as well as on
tumour cells carrying a single point mutation in the Ha-ras
oncogene, amplified c-myc or in CML cells, where the
bcr-abl translocation can be targeted. Oligonucleotide-
directed triple helix formation, where Hoogstein hydrogen
bonding permits the association of a third oligo strand with
the nuclear DNA, is described as an 'anti-gene' strategy. The
triple helix can be effectively stabilised by the attachment of a
'docking' intercalator molecule. It is envisaged that this
approach will interfere with the function of transcription
factors and restriction enzymes, thus disturbing differ-
entiation and cell division. The author concludes that the